| Modification of Requirements for Longitudinal Medical Study of Blast Pressure Exposure of Members of the Armed Forces and Collection of Exposure Information | S. 1790 NDAA Conference Report for FY 2020, 116-333, Sec. 742
| 12/21/2023 |
| Longitudinal Medical Study on Blast Pressure Exposure of Members of the Armed Forces | H.R. 2810 NDAA for FY 2018, Section 734(c)(2)
| 12/19/2023 |
| Parent Stress Index | H.R 7900 HASC Report for FY 2023, 117-397, Pg. 199
| 12/19/2023 |
| Sustainment of Critical Medical Skills | H.R 7900 HASC Report for FY 2023, 117-397, Pg. 205-206
| 12/13/2023 |
| Warfighter Brain Health | H.R 7900 HASC Report for FY 2023, 117-397, Pg. 210
| 12/7/2023 |
| Reports on Composition of Medical Personnel of Each Military Department and Related Matters | H.R.7776 NDAA for FY 2023, Sec. 746
| 12/5/2023 |
| Heat Illness Report | H.R. 4350 HASC Report for FY 2022, 117-118, Pg. 174 | 11/28/2023 |
| Report on the Effects of Long COVID on the Readiness and Retention of Servicemembers | H.R 7900, HASC Report for FY 2023, 117-397, Pg. 203
| 11/13/2023 |
| Report on Recording of Health Assessment Data in Military Health Records | H.R. 4200, NDAA Conference Report for FY 2005, 108-767, Sec. 739(a)(1)
| 11/13/2023 |
| TRICARE Dialysis Reimbursement | H.R 7900, HASC Report for FY 2023, 117-397, Pg. 207-208 | 11/13/2023 |
| Perfluorinated Chemicals Contamination and First Responder Exposure | H.R. 8236, DOD Approps for FY 2023 HAC-D Report, 117-388, Pg. 57 | 10/30/2023 |
| Department of Defense Report on Cardiac and Kidney Issues in Service Members Prior to and Following the COVID Vaccine Requirement | H.R 7900, HASC Report for FY 2023, 117-397, Pg. 186 | 9/29/2023 |
| Army Corps of Engineers Projects within the Defense Health Agency | H.R. 1625
DoD Approps Act
FY 2018
Joint Explanatory Statement
Pg. 998 | 9/13/2023 |
| Evaluation of the TRICARE Program FY 2023 Report to Congress | S. 1124 NDAA Conference Report for FY 1996 Sec. 717 As modified by S. 1356 NDAA Conference Report for FY 2016, Sec. 713
| 9/7/2023 |
| Individual First-Aid Kits Improvements | H.R. 4350, HASC Report for FY 2022, 117-118, Pg. 176 | 9/1/2023 |
| Negative Pressure Wound Therapy Review | H.R 7900, HASC Report for FY 2023, 117-397, Pg. 196-197 | 8/31/2023 |
| Novel Antibiotics Engineered to be Effective against Drug Resistant Bacteria | H.R 7900, HASC Report for FY 2023, 117-397, Pg. 198 | 8/31/2023 |
| TRICARE Qualifying Life Events – Substantive Interim | H.R 7900, HASC Report for FY 2023, 117-397, Pg. 208 | 8/28/2023 |
| Facilities, Sustainment, Restoration and Modernization | H.R. 133, Consolidated Approps for FY 2021, JES 116-68, Pg. 153 | 8/24/2023 |
| Body Composition Testing | H.R. 7617, HAC-D Report for FY 2021, 116-453, Pg. 65 | 8/24/2023 |
| National Disaster Medical System Surge Program – Substantive Interim | H.R 7900, HASC Report for FY 2023, 117-397, Pg. 195-196 | 8/16/2023 |
| Mental Health Access Standards | H.R 7900, HASC Report for FY 2023, 117-397, Pg. 194 | 8/16/2023 |
| Autism Care Demonstration Program Extension | H.R 7900 HASC Report for FY203 117-397, pg. 182 | 8/11/2023 |
| Mobile Applications for Mental Health Patients | H.R 7900 HASC Report for FY 2023 117-397, Pg. 195
| 8/9/2023 |
| Establishment of DOD System to Track and Record Information on Vaccine Administration | S. 1605 NDAA Conference Report for FY 2022 117-21, Sec. 716
| 8/1/2023 |
| Use of Fitness Wearables to Measure and Promote Readiness | H.R. 4350, HASC Report for FY 2022 ,117-118, Pg. 106-107 and H.R 7900, HASC Report for FY 2023, 117-397, Pg. 115
| 7/24/2023 |
| Carryover | H.R. 8236, DOD Approps for FY 2023 HAC-D Report, 117-388, Pg. 258
| 7/20/2023 |
| Annual Report on Autism Care Demonstration Program | S. 1376, SASC Report for FY 2016, 114-49, Pg. 157-158
| 7/17/2023 |
| TRICARE Comprehensive Autism Care Demonstration Program FY22 Q3 | S. 2943, SASC Report for FY 2017, 114-255, Pg. 205
| 7/17/2023 |
| TRICARE Comprehensive Autism Care Demonstration Program FY22 Q4 | S. 2943, SASC Report for FY 2017, 114-255, Pg. 205
| 7/17/2023 |
| Army Corps of Engineers Projects with the Defense Health Agency | H.R. 1625, DOD Approps Act, FY 2018, page 988 | 7/11/2023 |
| Health Care Provider Appointment and Compensation Authorities | S. 3254 SASC Report for FY203 112-173, pg. 132-133 | 6/28/2023 |
| Metastatic Cancer Research | H.R. 4432 HAC-D Report for FY 2022 177-88, Pg. 333-334 | 5/18/2023 |
| DOD Controlled Access to Health Information | H.R. 2471 Consolidated Approps for FY 2022, JES 117- 35, Pg. 148. DOD Approps SAC-D for FY 2022 Report, Pg. 220 | 4/26/2023 |
| Temporary Exemption for USUHS from Certain Paperwork Reduction Act Requirements | H.R. 6395 NDAA for FY 2021 Sec. 716
| 4/26/2023 |
| TRICARE Comprehensive Autism Care Demonstration Program | S. 2943 SASC Report for FY 2017, 114-255, Pg. 205 | 4/26/2023 |
| Pilot Program on Health Care Assistance System | S. 1605 NDAA Conference Report for FY 2022, 117-21, Section 705. H.R. 2810 NDAA for FY 2018, Section 731(d) | 4/18/2023 |
| TBI/PH | H.R. 133 Consolidated Approps for FY 2021, JES 116-68, Pg. 154. DOD Approps for FY 2021 SAC-D Report, Pg. 235-236 | 4/11/2023 |
| EHR | JES, DOD Approps for FY 2023, Pg. 111 & H.R. 8236 DOD Approps for FY 2023 HAC-D Report, 117-388, Pg. 260-261 | 4/6/2023 |
| Ocular Trauma Specialized Care | H.R. 117–118, pages 180-181, accompanying H.R. 4350, the NDAA for FY 2022 | 2/21/2023 |
| Extra Medical Maternal Health Providers Demonstration Project | H.R. 6395 NDAA for FY 2021 Sec. 746(f)(2)
| 2/14/2023 |
| Perfluorinated Chemicals (PFCs) Contamination and First Responder Exposure | H.R. 4432 HAC-D Report for FY 2022 117-88 Pg. 65
| 2/14/2023 |
| Army Corps of Engineers Projects within the Defense Health Agency | H.R. 1625 DoD Approps Act FY 2018 Joint Explanatory Statement Pg. 998
| 2/9/2023 |
| Study on the Incidence of Cancer Diagnosis and Mortality among Military Aviators and Aviation Support Personnel | H.R. 6395 NDAA for FY 2021 Sec. 750
| 2/9/2023 |
| Orthotics and Prosthetics Outcomes Research | H.R. 133 Consolidated Approps for FY 2021 JES 116-68 Pg. 154
| 2/8/2023 |
| Peer-Reviewed Cancer Research Programs | H.R. 7617 HAC-D Report for FY 2021 116-453 Pg. 333
| 2/8/2023 |
| Adverse Events Reported for Dietary Supplements | H.R. 4350, HASC Report for FY 2022, 117-118, Pg. 169
| 1/13/2023 |
| Anomalous Health Incidents/Havana Syndrome | H.R. 4432, HAC-D Report for FY 2022, 117-88, Pg. 9
| 1/13/2023 |